evertex fabrinology Inkomsten in het verleden
Verleden criteriumcontroles 3/6
evertex fabrinology's earnings have been declining at an average annual rate of -6.2%, while the Luxury industry saw earnings growing at 8.2% annually. Revenues have been declining at an average rate of 1.8% per year. evertex fabrinology's return on equity is 6.1%, and it has net margins of 9.2%.
Belangrijke informatie
-6.2%
Groei van de winst
-6.2%
Groei van de winst per aandeel
| Luxury Groei van de industrie | 8.2% |
| Inkomstengroei | -1.8% |
| Rendement op eigen vermogen | 6.1% |
| Nettomarge | 9.2% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price
Sep 16
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues
Mar 20Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?
Apr 25Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital
Mar 26evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Mar 05Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 12
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield
Jan 25Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?
Jan 07Is evertex fabrinology (TPE:1470) Headed For Trouble?
Dec 20evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Dec 02Opbrengsten en kosten
Hoe evertex fabrinology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 651 | 60 | 101 | 0 |
| 31 Mar 24 | 613 | 45 | 94 | 0 |
| 31 Dec 23 | 655 | 49 | 96 | 0 |
| 30 Sep 23 | 637 | 49 | 92 | 0 |
| 30 Jun 23 | 717 | 56 | 97 | 0 |
| 31 Mar 23 | 777 | 41 | 100 | 0 |
| 31 Dec 22 | 845 | 33 | 106 | 0 |
| 30 Sep 22 | 951 | 50 | 108 | 0 |
| 30 Jun 22 | 968 | 50 | 113 | 0 |
| 31 Mar 22 | 993 | 86 | 120 | 0 |
| 31 Dec 21 | 895 | 65 | 113 | 0 |
| 30 Sep 21 | 858 | 67 | 115 | 0 |
| 30 Jun 21 | 773 | 63 | 107 | 0 |
| 31 Mar 21 | 626 | 25 | 92 | 0 |
| 31 Dec 20 | 631 | 35 | 96 | 0 |
| 30 Sep 20 | 647 | 32 | 105 | 0 |
| 30 Jun 20 | 695 | 40 | 113 | 0 |
| 31 Mar 20 | 815 | 72 | 126 | 0 |
| 31 Dec 19 | 818 | 76 | 128 | 0 |
| 30 Sep 19 | 814 | 79 | 124 | 0 |
| 30 Jun 19 | 802 | 77 | 122 | 0 |
| 31 Mar 19 | 792 | 62 | 121 | 0 |
| 31 Dec 18 | 754 | 49 | 116 | 0 |
| 30 Sep 18 | 735 | 47 | 114 | 0 |
| 30 Jun 18 | 704 | 36 | 111 | 0 |
| 31 Mar 18 | 693 | 40 | 111 | 0 |
| 31 Dec 17 | 701 | 42 | 113 | 0 |
| 30 Sep 17 | 711 | 42 | 115 | 0 |
| 30 Jun 17 | 703 | 39 | 114 | 0 |
| 31 Mar 17 | 682 | 40 | 110 | 0 |
| 31 Dec 16 | 686 | 47 | 107 | 0 |
| 30 Sep 16 | 687 | 50 | 103 | 0 |
| 30 Jun 16 | 713 | 64 | 100 | 0 |
| 31 Mar 16 | 745 | 62 | 98 | 0 |
| 31 Dec 15 | 762 | 61 | 98 | 0 |
| 30 Sep 15 | 770 | 63 | 99 | 0 |
| 30 Jun 15 | 747 | 54 | 97 | 0 |
| 31 Mar 15 | 743 | 62 | 95 | 0 |
| 31 Dec 14 | 744 | 66 | 88 | 0 |
| 30 Sep 14 | 738 | 57 | 83 | 0 |
| 30 Jun 14 | 748 | 58 | 80 | 0 |
| 31 Mar 14 | 707 | 42 | 75 | 0 |
| 31 Dec 13 | 669 | 29 | 73 | 0 |
Kwaliteitswinsten: 1470 has high quality earnings.
Groeiende winstmarge: 1470's current net profit margins (9.2%) are higher than last year (7.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 1470's earnings have declined by 6.2% per year over the past 5 years.
Versnelling van de groei: 1470's earnings growth over the past year (7.5%) exceeds its 5-year average (-6.2% per year).
Winst versus industrie: 1470 earnings growth over the past year (7.5%) did not outperform the Luxury industry 11.2%.
Rendement op eigen vermogen
Hoge ROE: 1470's Return on Equity (6.1%) is considered low.